Responses
Abstracts accepted for publication
Rheumatoid arthritis - anti-TNF therapy
AB0278 Prolonging between-infusions interval is associated with positivity to anti-infliximab antibodies in rheumatoid arthritis and spondyloarthritis patients
Compose a Response to This Article
Other responses
No responses have been published for this article.